Category:

Regulatory

Award, fellowship & grant

Business and Market Strategy

Regulatory

Lupin Receives U.S. FDA Approval for Interchangeable Ranibizumab Biosimilar Ranluspec

Regulatory

FDA Launches One-Day Inspection Pilot to Enhance Risk-Based Oversight

Regulatory

FDA Novel Drug Approvals 2026 Q1: Full List & Insights

book/virender-singh-molecules-mentors-mindsets/

Regulatory

FDA Unveils Streamlined Guidelines for Biosimilar Industry Meetings

Regulatory

Biocon Biologics Marks U.S. Milestone: First Interchangeable Biosimilar Approval

Regulatory

FDA Novel Drug Therapy Approvals for 2025 | Quarter 2

Regulatory

FDA Approves Linvoseltamab for Advanced Multiple Myeloma Treatment

Regulatory

FDA Novel Drug Therapy Approvals for 2025 | Quarter 1

Regulatory

Biocon Biologics Secures U.S. FDA Approval for Jobevne

Regulatory

NABL Approves Shoolini Life Sciences Food Testing Facility

Regulatory

FDA Approves First Rapid-Acting Insulin Biosimilar, Merilog

Regulatory

FDA approved Datroway for Metastatic Breast Cancer

book/virender-singh-molecules-mentors-mindsets/

How AI is Transforming Oral Cancer Screening in India: The Story of Mukhia+

June 30, 2026

Protoporphyrin IX regulates the phase separation behavior of α-Synuclein

June 29, 2026

Targeting a Bacterial Master Regulator to Combat Drug-Resistant Pneumonia

June 27, 2026

Biopharmaceuticals to Shape Future of Healthcare, India Aims to Launch 100 Biologics by 2047

June 26, 2026

Health Ministry Expands QR Code-Based Drug Traceability to Vaccines, Antimicrobials and Cancer Medicines

June 26, 2026